Fairvalue-Calculator Fairvalue-Calculator
EN DE

Vizionfocus Inc (4771) Fair Value & Analysis

Healthcare · TW · Market cap 11.1B TWD

Price190.50 TWD
Fair Value275.23 TWD
Upside+44.5%
Quality86/100
Evidence: Medium Range 206.43 TWD – 439.21 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Vizionfocus Inc (4771) currently trades at 190.50 TWD, while our model-based Fair Value estimate is 275.23 TWD — implying the stock looks roughly 44.5% undervalued today. We read business quality at 86/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Vizionfocus Inc. engages in the manufacturing of medical equipment in Japan, China, Southeast Asia and the United States. It also manufactures mechanical equipment, optical instruments, and precision instruments; trades internationally; and provides other consulting services. In addition, the company engages in the research and development, design, OEM, development, and sale of contact lenses, as well as customized services. Vizionfocus Inc. was founded in 2012 and is headquartered in Miaoli, Taiwan.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Vizionfocus Inc (4771) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 275.23 TWD versus a price of 190.50 TWD — about +44% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 4771?
Our 21-model fair value for Vizionfocus Inc is 275.23 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 190.50 TWD.
What is the quality score of 4771?
Vizionfocus Inc has a Quality Score of 86/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.